U.S. flag

An official website of the United States government

NM_001035.3(RYR2):c.11863C>A (p.Gln3955Lys) AND Catecholaminergic polymorphic ventricular tachycardia 1

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Feb 2, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002471405.1

Allele description [Variation Report for NM_001035.3(RYR2):c.11863C>A (p.Gln3955Lys)]

NM_001035.3(RYR2):c.11863C>A (p.Gln3955Lys)

Gene:
RYR2:ryanodine receptor 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q43
Genomic location:
Preferred name:
NM_001035.3(RYR2):c.11863C>A (p.Gln3955Lys)
HGVS:
  • NC_000001.11:g.237778753C>A
  • NG_008799.3:g.741570C>A
  • NM_001035.3:c.11863C>AMANE SELECT
  • NP_001026.2:p.Gln3955Lys
  • LRG_402t1:c.11863C>A
  • LRG_402:g.741570C>A
  • LRG_402p1:p.Gln3955Lys
  • NC_000001.10:g.237942053C>A
  • NM_001035.2:c.11863C>A
Protein change:
Q3955K
Links:
dbSNP: rs1558393802
NCBI 1000 Genomes Browser:
rs1558393802
Molecular consequence:
  • NM_001035.3:c.11863C>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Catecholaminergic polymorphic ventricular tachycardia 1
Synonyms:
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; VENTRICULAR TACHYCARDIA, STRESS-INDUCED POLYMORPHIC 1
Identifiers:
MONDO: MONDO:0011484; MedGen: C1631597; Orphanet: 3286; OMIM: 604772

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002767430Victorian Clinical Genetics Services, Murdoch Childrens Research Institute

See additional submitters

criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Feb 2, 2022)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The binding of the RyR2 calcium channel to its gating protein FKBP12.6 is oppositely affected by ARVD2 and VTSIP mutations.

Tiso N, Salamon M, Bagattin A, Danieli GA, Argenton F, Bortolussi M.

Biochem Biophys Res Commun. 2002 Dec 13;299(4):594-8.

PubMed [citation]
PMID:
12459180

Clinical utility gene card for: Catecholaminergic polymorphic ventricular tachycardia (CPVT).

Napolitano C, Bloise R, Memmi M, Priori SG.

Eur J Hum Genet. 2014 Jan;22(1). doi: 10.1038/ejhg.2013.55. Epub 2013 Apr 3. No abstract available.

PubMed [citation]
PMID:
23549275
PMCID:
PMC3865399
See all PubMed Citations (6)

Details of each submission

From Victorian Clinical Genetics Services, Murdoch Childrens Research Institute, SCV002767430.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Likely pathogenic. Following criteria are met: 0103 - Dominant negative and gain of function are known mechanisms of disease in this gene and are associated with catecholaminergic polymorphic ventricular tachycardia 1 (CPVT; MIM#604772) (PMIDs: 12459180, 27646203, 29477366). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0112 - The condition associated with this gene has incomplete penetrance. Penetrance for CPVT is estimated to be 60-70% (PMID: 23549275). (I) 0200 - Variant is predicted to result in a missense amino acid change from glutamine to lysine. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0602 - Variant is located in a hotspot region or cluster of pathogenic variants (Decipher; PMID: 30696458). (SP) 0710 - Other missense variants comparable to the one identified in this case have inconclusive previous evidence for pathogenicity. The p.(Gln3395Glu) variant has been classified once as likely pathogenic, primarily because it has been observed by Invitae in-house as de novo in CPVT individuals while the p.(Gln3395His) variant has been classified as a VUS (ClinVar). (I) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1204 - This variant has been shown to be de novo in the proband (parental status not tested but assumed) (by segregation analysis). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 16, 2025